Malignant mesothelioma in the peritoneal cavity – a case report
Authors:
K. Rupert; V. Třeška
Authors‘ workplace:
Chirurgická klinika FN Plzeň a LF UK v Plzni, přednosta: prof. MUDr. V. Třeška, DrSc.
Published in:
Rozhl. Chir., 2015, roč. 94, č. 4, s. 166-169.
Category:
Case Report
Overview
Malignant mesothelioma is a rare tumour with an incidence of 0.5−3 cases per million inhabitants. Only about 20% of cases occur in the peritoneum.
The authors use the case report of a male patient with malignant mesothelioma occurring in the peritoneal cavity to demonstrate the difficulty of preoperative diagnosis: preoperative examinations made the authors consider a primary liver tumour and only definitive histological examination revealed the diagnosis.
The discussion deals with the epidemiology, diagnosis and treatment of this rare disease and underlines the unique role of surgical therapy in its management.
Key words:
malignant mesothelioma − surgical treatment
Sources
1. Raza A, Huang WC, Takabe K. Advances in the management of peritoneal mesothelioma. World J Gastroenterol 2014;20:11700−12.
2. Deraco M, Nonaka D, Baratti D, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006;13:229–37.
3. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007;18:985–90.
4. Welch LS, Acherman YI, Haile E, et al. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health 2005;11:254–258.
5. Chua TC, Chong CH, Morris DL. Peritoneal mesothelioma: current status and future directions. Surg Oncol Clin N Am 2012;21:635–43.
6. Del Gobbo A, Fiori S, Gaudioso G, et al. Synchronous pleural and peritoneal malignant mesothelioma: a case report and review of literature. Int J Clin Exp Pathol 2014;7:2484–9.
7. Miura JT, Johnston FM, Gamblin TC, et al. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol 2014;21:3947–53.
8. Alexander HR, Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 2013;153:779–86.
9. Cao C, Yan TD, Deraco M, et al. Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol 2012;23:1494–8.
10. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003;21:4560–7.
11. Pillai K, Pourgholami MH, Chua TC, et al. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J Cancer Res Clin Oncol 2013;139:987–94.
12. Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009;27:6237–42.
13. Yan TD, Deraco M, Elias D, et al. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer 2011;117:1855–63.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2015 Issue 4
Most read in this issue
- The ONSTEP inguinal hernia repair technique
- Massive small intestine bleeding: CT-angiography and surgical treatment – a case report
- Acute necrotizing pancreatitis: traditional laparotomy vs. minimally invasive procedures
- The past and present of thumb reconstruction